162 related articles for article (PubMed ID: 17943534)
1. Comparative effects of dydrogesterone and medroxyprogesterone acetate in critical areas: the brain and the vessels.
Simoncini T; Mannella P; Pluchino N; Genazzani AR
Gynecol Endocrinol; 2007 Oct; 23 Suppl 1():9-16. PubMed ID: 17943534
[TBL] [Abstract][Full Text] [Related]
2. Progestogens and brain: an update.
Pluchino N; Cubeddu A; Giannini A; Merlini S; Cela V; Angioni S; Genazzani AR
Maturitas; 2009 Apr; 62(4):349-55. PubMed ID: 19167174
[TBL] [Abstract][Full Text] [Related]
3. Hormone therapy and the cardiovascular system: the critical role of progestins.
Sitruk-Ware RL
Climacteric; 2003 Oct; 6 Suppl 3():21-8. PubMed ID: 15018245
[TBL] [Abstract][Full Text] [Related]
4. Progestogen metabolism.
Lobo RA
J Reprod Med; 1999 Feb; 44(2 Suppl):148-52. PubMed ID: 11392024
[TBL] [Abstract][Full Text] [Related]
5. Effects of progestins of human proliferative endometrium: an in vitro model of potential clinical relevance.
Illouz S; Dales JP; Sferlazzo K; Garcia S; Carpentier-Meunier S; Boubli L; Lavaut MN; Charpin C
Int J Mol Med; 2003 Oct; 12(4):517-23. PubMed ID: 12964029
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the difference in histopathology and cell cycle kinetics among the postmenopausal endometrium treated with different progestins in sequential-combined hormone replacement therapy.
Chang TC; Chen M; Lien YR; Chen RJ; Chow SN
Menopause; 2003; 10(2):172-8. PubMed ID: 12627044
[TBL] [Abstract][Full Text] [Related]
7. Progestogens in the treatment of secondary amenorrhea.
Simon JA
J Reprod Med; 1999 Feb; 44(2 Suppl):185-90. PubMed ID: 11392030
[TBL] [Abstract][Full Text] [Related]
8. Selectivity and potency of the retroprogesterone dydrogesterone in vitro.
Rižner TL; Brožič P; Doucette C; Turek-Etienne T; Müller-Vieira U; Sonneveld E; van der Burg B; Böcker C; Husen B
Steroids; 2011 May; 76(6):607-15. PubMed ID: 21376746
[TBL] [Abstract][Full Text] [Related]
9. Progestogens and cardiovascular disease. A critical review.
Clarkson TB
J Reprod Med; 1999 Feb; 44(2 Suppl):180-4. PubMed ID: 11392029
[TBL] [Abstract][Full Text] [Related]
10. Progestogens and target tissues: vascular systems.
Mueck AO; Seeger H
Maturitas; 2009 Apr; 62(4):356-61. PubMed ID: 19157733
[TBL] [Abstract][Full Text] [Related]
11. Molecular mechanisms of steroid receptor-mediated actions by synthetic progestins used in HRT and contraception.
Africander D; Verhoog N; Hapgood JP
Steroids; 2011 Jun; 76(7):636-52. PubMed ID: 21414337
[TBL] [Abstract][Full Text] [Related]
12. The bioidentical hormone debate: are bioidentical hormones (estradiol, estriol, and progesterone) safer or more efficacious than commonly used synthetic versions in hormone replacement therapy?
Holtorf K
Postgrad Med; 2009 Jan; 121(1):73-85. PubMed ID: 19179815
[TBL] [Abstract][Full Text] [Related]
13. Progestins in HRT: sufferance or desire?
Skouby SO; Jespersen J
Maturitas; 2009 Apr; 62(4):371-5. PubMed ID: 19203850
[TBL] [Abstract][Full Text] [Related]
14. Could transdermal estradiol + progesterone be a safer postmenopausal HRT? A review.
L'hermite M; Simoncini T; Fuller S; Genazzani AR
Maturitas; 2008; 60(3-4):185-201. PubMed ID: 18775609
[TBL] [Abstract][Full Text] [Related]
15. Short-term effects of two continuous combined oestrogen-progestogen therapies on several cardiovascular risk markers in healthy postmenopausal women: a randomised controlled trial.
de Kraker AT; Kenemans P; Smolders RG; Kroeks MV; van der Mooren MJ
Eur J Obstet Gynecol Reprod Biol; 2009 Feb; 142(2):139-44. PubMed ID: 19095343
[TBL] [Abstract][Full Text] [Related]
16. Synthetic progestins used in HRT have different glucocorticoid agonist properties.
Koubovec D; Ronacher K; Stubsrud E; Louw A; Hapgood JP
Mol Cell Endocrinol; 2005 Oct; 242(1-2):23-32. PubMed ID: 16125839
[TBL] [Abstract][Full Text] [Related]
17. Progestins inhibit the neuroprotective effects of estrogen in rat hippocampus.
Rosario ER; Ramsden M; Pike CJ
Brain Res; 2006 Jul; 1099(1):206-10. PubMed ID: 16793026
[TBL] [Abstract][Full Text] [Related]
18. The effects of estrogen therapy and estrogen combined with different androgenic progestins on carbohydrate and lipid metabolism in overweight-obese younger postmenopausal women.
Demir B; Ozturkoglu E; Solaroglu A; Baskan B; Kandemir O; Karabulut E; Haberal A
Gynecol Endocrinol; 2008 Jun; 24(6):347-53. PubMed ID: 18584415
[TBL] [Abstract][Full Text] [Related]
19. Effects of dydrogesterone on the vascular system.
Seeger H; Mueck AO
Gynecol Endocrinol; 2007 Oct; 23 Suppl 1():2-8. PubMed ID: 17943533
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular effects of medroxyprogesterone acetate and progesterone: a case of mistaken identity?
Hermsmeyer RK; Thompson TL; Pohost GM; Kaski JC
Nat Clin Pract Cardiovasc Med; 2008 Jul; 5(7):387-95. PubMed ID: 18521110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
